These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15075569)

  • 21. Low frequency of hypersensitivity reactions to abacavir in HIV infected patients in a referral center in Bahia, Brazil.
    Barreto RG; Brites C
    Braz J Infect Dis; 2019; 23(4):268-270. PubMed ID: 31374183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypersensitivity reactions due to abacavir.
    Newsline People AIDS Coalit N Y; 1998 Feb; ():35-6. PubMed ID: 11367446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abacavir rechallenge has to be avoided in case of hypersensitivity reaction.
    Escaut L; Liotier JY; Albengres E; Cheminot N; Vittecoq D
    AIDS; 1999 Jul; 13(11):1419-20. PubMed ID: 10449301
    [No Abstract]   [Full Text] [Related]  

  • 24. [Delayed drug sensitivity].
    del Valle Loarte P; Cervero Jiménez M; Joya Seijo MD; Jusdado Ruiz-Capillas JJ; Torres Perea R
    Rev Clin Esp; 2003 Dec; 203(12):617-8. PubMed ID: 14622520
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypersensitivity reactions reported with abacavir.
    AIDS Patient Care STDS; 1998 May; 12(5):405-6. PubMed ID: 11361980
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypersensitivity reactions in patients treated with abacavir: strategies to avoid such reactions.
    Kapoor S
    AIDS Patient Care STDS; 2008 Oct; 22(10):769. PubMed ID: 18778242
    [No Abstract]   [Full Text] [Related]  

  • 27. Abacavir hypersensitivity reaction: an update.
    Hughes CA; Foisy MM; Dewhurst N; Higgins N; Robinson L; Kelly DV; Lechelt KE
    Ann Pharmacother; 2008 Mar; 42(3):387-96. PubMed ID: 18303141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newly approved abacavir to carry hypersensitivity warning.
    Miller JL
    Am J Health Syst Pharm; 1999 Feb; 56(4):304. PubMed ID: 10690211
    [No Abstract]   [Full Text] [Related]  

  • 29. Comment: Abacavir hypersensitivity reaction: an update.
    Hughes CA; Foisy MM; Dewhurst N; Higgins N; Robinson L; Kelly DV; Lechelt KE
    Ann Pharmacother; 2008 Oct; 42(10):1519-20; author reply 1520-1. PubMed ID: 18780810
    [No Abstract]   [Full Text] [Related]  

  • 30. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity.
    Manglani MV; Gabhale YR; Lala MM; Sekhar R; More D
    Indian Pediatr; 2018 Feb; 55(2):140-141. PubMed ID: 29242412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of patch testing for the diagnosis of abacavir-related hypersensitivity reaction in HIV patients.
    Giorgini S; Martinelli C; Tognetti L; Carocci A; Giuntini R; Mastronardi V; Torricelli F; Leoncini F; Lotti T
    Dermatol Ther; 2011; 24(6):591-4. PubMed ID: 22515676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kawasaki-like syndrome: abacavir hypersensitivity?
    Toerner JG; Cvetkovich T
    Clin Infect Dis; 2002 Jan; 34(1):131-3. PubMed ID: 11731962
    [No Abstract]   [Full Text] [Related]  

  • 33. Abacavir hypersensitivity reaction after switching from the twice-daily to the once-daily formulation.
    Gervasoni C; Vigano O; Grinelli E; Ortu M; Galli M; Rusconi S
    AIDS Patient Care STDS; 2007 Jan; 21(1):1-3. PubMed ID: 17263652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe hypersensitivity reactions following reintroduction of abacavir.
    AIDS Read; 2000 Sep; 10(9):525. PubMed ID: 11019447
    [No Abstract]   [Full Text] [Related]  

  • 35. Response to: Are all non-thymidine analogue backbones appropriate for treating antiretroviral-naïve patients?
    Brothers C; Cutrell A; Scott T; Hernandez J; Moult A
    Int J Clin Pract; 2006 May; 60(5):611-2; author reply 612. PubMed ID: 16700867
    [No Abstract]   [Full Text] [Related]  

  • 36. Current trends in screening across ethnicities for hypersensitivity to abacavir.
    Rodriguez-Nóvoa S; Soriano V
    Pharmacogenomics; 2008 Oct; 9(10):1531-41. PubMed ID: 18855539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abacavir warning: certain respiratory symptoms can indicate hypersensitivity reaction.
    AIDS Treat News; 2000 Feb; (No 337):7-8. PubMed ID: 11367210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypersensitivity related to abacavir in two members of a family.
    Peyrieère H; Nicolas J; Siffert M; Demoly P; Hillaire-Buys D; Reynes J
    Ann Pharmacother; 2001 Oct; 35(10):1291-2. PubMed ID: 11675863
    [No Abstract]   [Full Text] [Related]  

  • 39. Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study.
    Rauch A; Nolan D; Martin A; McKinnon E; Almeida C; Mallal S
    Clin Infect Dis; 2006 Jul; 43(1):99-102. PubMed ID: 16758424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological risk factors for hypersensitivity reactions to abacavir.
    Easterbrook PJ; Waters A; Murad S; Ives N; Taylor C; King D; Vyakarnam A; Thorburn D
    HIV Med; 2003 Oct; 4(4):321-4. PubMed ID: 14525543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.